[1] 郑 杰. 积极规范的开展肿瘤靶向病理诊断[J].中华病理学杂志,2013,42(1):1-3.
[2] President Obama’S State of The Union Address-Remarks As Prepared For Delivery [EB/OL]. https: //medium. com/@ White-House/ president- obamas-state-of-the-union-address-remarks-as-prepared-for-delivery-55f9825449b2. Accessed 2015-03-01.
[3] 张佳星.专访曹雪涛院士: 推进精准医学发展助力健康中国建设[EB/OL]. http: //www.biodiscover.com/news/celebrity/117614.html. accessed at 2015-03-09.
[4] CSCO胃肠道间质瘤专家委员会.中国胃肠道间质瘤诊断治疗共识[J].临床肿瘤学杂志, 2013, 18(11):1025-1032.
[5] 卫生部病理质控与评价中心, 结肠直肠癌KRAS基因突变检测专家组.结肠直肠癌KRAS基因突变检测专家共识[J].中华病理学杂志,2012,41,(9):635-636.
[6] 中国非小细胞肺癌患者表皮生长因子受体基因突变检测专家组.中国非小细胞肺癌患者表皮生长因子受体基因突变检测专家共识 [J].中华病理学杂志, 2011, 40(10):700-702.
[7] 来茂德.中国病理学发展的现状和未来 [J].中华病理学杂志,2012, 41(1):1-3.
[8] Lang J H, Wecsler J S, Press M F, et al.Molecular markers for breast cancer diagnosis, prognosis and targeted therapy[J].J Surg Oncol,2015,111(1):81-90.
[9] Vilar E, Gruber S B. Microsatellite instability in colorectal cancer the stable evidence[J].Nat Rev Clin Oncol,2010,7(3):153-162.
[10] Borràs E, Jurado I, Hernan I, et al. Clinical pharmacogenomic testing of KRAS, BRAF and EGFR mutations by high resolution melting analysis and ultra-deep pyrosequencing[J].BMC Canaer,2011,11:406.
[11] Walk E E. The role of pathologists in the era of personalized medicine [J]. Arch Pathol Lab Med,2009,133(4):605-610.
[12] 周晓军.个体化医疗时代:临床病理研究生的机遇和挑战[J].医学研究生学报,2013,26(1):1-3.
[13] Hou J, Aerts J, den Hamer B, et al. Gene expression-based classification of non-small cell lung carcinomas and survival prediction[J].PloS Ons,2010,5(4):e10312.
[14] 王建东,周晓军. 分子病理检查的规范化问题及建议[J].临床与实验病理学杂志,2012,28(1):64-66.